Donald E. Low
Mount Sinai Hospital/University Health Network
Toronto
Ontario
Canada
Name/email consistency: high
- FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia. Low, D.E., File, T.M., Eckburg, P.B., Talbot, G.H., David Friedland, H., Lee, J., Llorens, L., Critchley, I.A., Thye, D.A. J. Antimicrob. Chemother. (2011)
- Antimicrobial susceptibility among bacterial isolates from ICU and non-ICU setting and different age groups: results from the tigecycline evaluation and Surveillance trial in North America. Low, D.E., Markovic, M.J., Dowzicky, M.J. J. Chemother (2009)
- Reducing antibiotic use in influenza: challenges and rewards. Low, D. Clin. Microbiol. Infect. (2008)
- Pandemic planning: non-pharmaceutical interventions. Low, D.E. Respirology (2008)
- Progressive and nonresolving pneumonia. Low, D.E., Mazzulli, T., Marrie, T. Curr. Opin. Pulm. Med (2005)
- Changing trends in antimicrobial-resistant pneumococci: it's not all bad news. Low, D.E. Clin. Infect. Dis. (2005)
- Clinical and bacteriological efficacy of the ketolide telithromycin against isolates of key respiratory pathogens: a pooled analysis of phase III studies. Low, D.E., Brown, S., Felmingham, D. Clin. Microbiol. Infect. (2004)
- Why SARS will not return: a polemic. Low, D.E. CMAJ (2004)
- Quinolone resistance among pneumococci: therapeutic and diagnostic implications. Low, D.E. Clin. Infect. Dis. (2004)
- Activity of telithromycin against key pathogens associated with community-acquired respiratory tract infections. Low, D.E., Felmingham, D., Brown, S.D., Rangaraju, M., Nusrat, R. J. Infect. (2004)
- Resistance trends in Haemophilus influenzae (PROTEKT years 1-3 [1999-20021). Low, D.E. J. Chemother (2004)
- Activity of BMS-284756, a novel des-fluoro(6) quinolone, against Staphylococcus aureus, including contributions of mutations to quinolone resistance. Low, D.E., Muller, M., Duncan, C.L., Willey, B.M., de Azavedo, J.C., McGeer, A., Kreiswirth, B.N., Pong-Porter, S., Bast, D.J. Antimicrob. Agents Chemother. (2002)
- Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000. Low, D.E., de Azavedo, J., Weiss, K., Mazzulli, T., Kuhn, M., Church, D., Forward, K., Zhanel, G., Simor, A., McGeer, A. Antimicrob. Agents Chemother. (2002)
- Activity of GAR-936 and other antimicrobial agents against North American isolates of Staphylococcus aureus. Low, D.E., Kreiswirth, B.N., Weiss, K., Willey, B.M. Int. J. Antimicrob. Agents (2002)
- The era of antimicrobial resistance-implications for the clinical laboratory. Low, D.E. Clin. Microbiol. Infect. (2002)
- Antimicrobial drug use and resistance among respiratory pathogens in the community. Low, D.E. Clin. Infect. Dis. (2001)